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in the developing rat brain
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Abstract
Energy use in the brain constrains its information processing power, but only about half the brain’s energy consumption is
directly related to information processing. Evidence for which non-signalling processes consume the rest of the brain’s
energy has been scarce. For the first time, we investigated the energy use of the brain’s main non-signalling tasks with a
single method. After blocking each non-signalling process, we measured oxygen level changes in juvenile rat brain slices
with an oxygen-sensing microelectrode and calculated changes in oxygen consumption throughout the slice using a
modified diffusion equation. We found that the turnover of the actin and microtubule cytoskeleton, followed by lipid
synthesis, are significant energy drains, contributing 25%, 22% and 18%, respectively, to the rate of oxygen consumption.
In contrast, protein synthesis is energetically inexpensive. We assess how these estimates of energy expenditure relate to
brain energy use in vivo, and how they might differ in the mature brain.
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Introduction
Energy availability limits information processing in the
brain,1–3 which consumes energy disproportionately in
relation to its fraction of total body mass.4,5 The brain’s
most salient feature is neuronal communication, and
the energetic cost of the diﬀerent cellular processes
underlying signalling has been well described.1–3,6–11
Most energy use is on the removal of sodium ions that
enter neurons to generate synaptic and action poten-
tials.1,6,11 However, inhibiting the sodium–potassium
ATPase, without which signalling activity ceases, has
shown that around 45% of the brain’s baseline energy
use in vivo is consumed on non-signalling processes,12
which is considerably more than is estimated or assumed
in many models of brain energy use.1,11,13,14 Surprisingly,
it is largely unknown which non-signalling processes con-
sume the rest of the brain’s energy.
Often called ‘housekeeping’ processes, the many
tasks that the brain performs in addition to signalling
provide the scaﬀold on which signalling, plasticity and
the encoding of memory can occur. The actin cytoskel-
eton regulates the morphology of the mature neuron, as
well as its growth in development,15–18 and modulates
synaptic function.19,20 To do this, the actin cytoskeleton
treadmills continuously, by adding G-actin monomers
to one end of strands of F-actin and releasing them
at the other end.21 Along the F-actin polymer,
ATP bound to G-actin gets hydrolysed to ADP.22
Bernstein and Bamburg23 claimed that actin cycling
accounted for half of all energy use in neuronal cultures
but, as their experimental method suppresses neuronal
glutamate release, this fraction is likely to be overesti-
mated.24 Conversely, modelling of actin and micro-
tubule turnover suggested that less than 1% of total
brain energy use was spent on actin treadmilling, and
even less on microtubule turnover.24 Experimental data
on the energetic cost of microtubule turnover are
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lacking, even though microtubules also exist in a state
of dynamic instability, growing and shrinking in an
energy-dependent manner, and hydrolysing tubulin-
bound GTP along the way.25–28
Alongside continuous actin and microtubule restruc-
turing, phospholipids and proteins must be synthesised
in the brain. Experimental data for the energy use of
either process are scarce, but protein synthesis was esti-
mated theoretically to account for no more than 2% of
the total consumption of ATP in the brain1,29 and
retina.14 While phospholipid synthesis was once thought
to be similarly inexpensive,14,30 Purdon and Rapoport31
calculated that up to 25% of total brain ATP may be
used on phospholipid metabolism, mainly on mainten-
ance of the phosphorylation state of lipids (12%), with
another 8% of total ATP spent on transport of
phospholipids through the phospholipid bilayer to main-
tain lipid asymmetry across the membrane,32 and 5% on
recycling and incorporation of short-lived fatty acids
inside phospholipids.
Here, we present the ﬁrst experimental evidence
investigating, with a single approach, the relative con-
tributions of the main non-signalling processes to the
developing brain’s energy budget. We blocked actin
treadmilling, microtubule turnover, or lipid or protein
synthesis in developing rat brain slices. By measuring
oxygen level changes with an oxygen-sensing microelec-
trode as a proxy for energy expenditure, and modelling
oxygen use throughout the slice, we could estimate the
energy used on each process.
Materials and methods
Slice preparation
Experimental protocols were approved by UCL’s Animal
Welfare and Ethical Review Body. Procedures complied
with the regulations of the Animals (scientiﬁc procedures)
Act 1986 and reporting follows the ARRIVE (animal
research: reporting of in vivo experiments) guidelines.
Following cervical dislocation (no anaesthesia was
required for animals of the age and size used), hippocam-
pal slices (300mm thick) from male and female P10
rats were cut on a Leica VT1200 S vibratome using ice-
cold slicing solution containing (mM) 124 NaCl,
10 D-glucose, 26 NaHCO3, 2.5 KCl, 1 NaH2PO4,
2 MgCl2, 2.5 CaCl2 and 1 kynurenic acid (bubbled with
95% O2/5% CO2). The dissection followed the ‘magic
cut’ method to maintain synaptic connectivity, using an
angle of 10 for the ‘magic cut’ to preserve the CA1
region.33 Slices were used one to ﬁve hours after slicing.
HEPES-buﬀered artiﬁcial cerebrospinal ﬂuid (aCSF),
to which blockers were added, was bath-applied (at
2.5ml/min), while submerged slices rested on the glass
bottom of a bath on the Zeiss LSM 710 microscope
stage. The bath volume was 2ml, and solution ﬂowed
over the top, but not the bottom, of the slice. Slices and
electrode placement were observed using a 25 lens. The
aCSF pH was adjusted to 7.4 with NaOH, and con-
tained (mM) 140 NaCl, 10 D-glucose, 2.5 KCl,
10 HEPES, 1 NaH2PO4, 1 MgCl2 and 2 CaCl2 (osmo-
larity 300 mmol/kg, bubbled with 100% oxygen, and
heated to 36–37C).
Pharmacology
To establish whether spontaneous signalling had a detect-
able eﬀect on O2 consumption, postsynaptic currents
were inhibited with 10mM NBQXþ 50mM D-AP5, pre-
synaptic transmitter release and postsynaptic events were
blocked with 250mM cadmium, or action potentials and
evoked synaptic events were inhibited with 1mM TTX.
Actin polymerisation was reversibly blocked with cyto-
chalasin D, which binds to the plus end of F-actin and
prevents G-actin monomer attachment.34 Cytochalasin
does not aﬀect action potential propagation and duration
in cardiac muscle cells.35 Cytochalasin D was dissolved in
DMSO and made up in aCSF to a ﬁnal concentration of
10mM.When cytochalasin is applied extracellularly, max-
imal inhibitory eﬀects are achieved with a concentration
of 10mM, and the time needed for maximal eﬃcacy is
three to four minutes.34 In order to verify that cytocha-
lasin D does indeed inhibit actin treadmilling, we imaged
isolectin B4 labelled microglia in hippocampal slices (see
Supplementary Methods and Supplementary Figure 1).
At rest, microglia constantly survey the brain by
moving their processes.36 If actin treadmilling is inhibited,
the continuous rearrangement of actin underlying micro-
glial process movement should cease, and motility should
decline.
Cytochalasin D, the most potent of the cytochala-
sins, was chosen over jasplakinolide, another inhibitor
of actin treadmilling, because the latter can promote
F-actin polymerization as well as stabilization,37,38 and
apoptosis,39 and was preferred over latrunculin because
the latter drug distorts cell shape far more than cytocha-
lasin D.40 Nevertheless, we also applied jasplakinolide to
some slices, as Bernstein and Bamburg23 stated that it
reduced ATP use more eﬀectively than cytochalasin D in
neuronal cultures. In hippocampal slices, jasplakinolide
has been used at concentrations from 0.1–10mM41,37
without changing the electrophysiological properties of
neurons.41 We used 1mM.
Microtubule turnover was reversibly inhibited with
25mM nocodazole (dissolved in DMSO), a non-cytotoxic
microtubule-depolymerizing agent binding to beta-
tubulin.42 This concentration was shown to be eﬀective
when bath-applied onto hippocampal slices without alter-
ing neuronal electrophysiological characteristics,43 and
nocodazole depolymerises microtubules within minutes.44
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To arrest fatty acid synthesis, we used 60 mM 5-(tet-
radecyloxy)-2 furoic acid (TOFA), which inhibits the
acetyl-CoA carboxylase required to catalyse the carb-
oxylation of acetyl-CoA.45 TOFA was dissolved in
DMSO and 0.5% albumin to avoid precipitation. On
adipocytes, 50 mM TOFA is eﬃcacious within 15min.46
Application of 60 mM TOFA for up to one hour does
not alter neuronal viability.45
Anisomycin, an inhibitor of mRNA translation, was
used at 20 mM (dissolved in DMSO) to inhibit protein
synthesis. Anisomycin blocks protein synthesis within
minutes at this concentration in hippocampal slices
without aﬀecting basal synaptic transmission.47,48
To inhibit the sodium–potassium ATPase, 1mM
ouabain was applied for 10min in external solutions
containing either 2mM Ca2þ or 2mM EGTA. To
block all oxidative phosphorylation, 25 mM antimycin
was applied for 20min.
Equal percentages (see Supplementary Methods) of
solvents or carrier proteins used were added to all the
extracellular solutions in any particular experiment in
order to rule out any confounding eﬀects they may
have. See Supplementary Methods for drug prepar-
ation and purchasing information.
Oxygen recordings
A Unisense Clark-type oxygen microsensor (OX-10),
which generates a current proportional to the oxygen
concentration,49 was used to measure the oxygen level
at the slice surface (in the CA1 region of the hippocam-
pus) and at three diﬀerent depths in the slice before,
during and after the application of a blocker of each
non-signalling process (see Figure 1 and Supplementary
Methods). Recordings were calibrated (Figure 1(d))
using solutions bubbled with known partial pressures
of oxygen (converted to mM using Henry’s law and the
solubility50 of O2: see Supplementary Methods).
Since the electrode moved across the hippocampus
when being lowered into the slice along its axis (starting
from CA1 and usually not venturing beyond the stratum
lacunosum-moleculare), we established that the baseline
oxygen level was similar throughout the hippocampus by
measuring the surface oxygen level at 28 points across 9
hippocampal regions (Figure 2(a) and (b)). We further
determined the energy consumption on spontaneous
electrical signalling in the hippocampal slice by blocking
distinct signalling related processes (Figure 2(c)).
Modelling oxygen consumption through the slice
The [O2] depth proﬁles obtained in each condition were
used to model oxygen consumption throughout the
slice, as in Hall et al.51 The depth proﬁle data points,
obtained during continuous ﬂow of the solution
superfusing the slice, were ﬁtted with steady-state solu-
tions of the following modiﬁed diﬀusion equation
D
@2c
@x2
¼ cVmax
cþ Km ð1Þ
where D¼ 1.54 109 m2/s is the diﬀusion coeﬃcient of
O2 in brain at 37
C,52 c is oxygen concentration, x is
distance into the slice in mm, Vmax denotes the maximum
rate of oxidative phosphorylation at saturating oxygen
concentration in mM/min, and Km¼1mM53 is the EC50
for oxygen activating oxidative phosphorylation. In
equation (1), the left-hand side represents diﬀusion and
the right-hand side represents the consumption of
oxygen by mitochondria. This was solved using the
pdepe function in MATLAB (the MathWorks; scripts
available on request). At the bottom of the slice, we
applied the boundary condition dc/dx¼ 0.
Above the surface of a slice, there is an unstirred layer
of solution with no oxygen consumption, but only
oxygen diﬀusion towards the slice from the bulk solution
above51,54 with a diﬀusion coeﬃcient for oxygen in water
at 37C of 2.68 109 m2/s.55 Consequently, the oxygen
concentration in the unstirred layer gradually
approaches that of the bulk solution with greater dis-
tance from the membrane.54 In slices across all experi-
mental conditions, the unstirred layer was measured
after the experiment and incorporated into the ﬁts of
slice oxygen data in order to more accurately estimate
changes in O2 consumption in the slice from changes in
the O2 depth proﬁles (see Supplementary Methods).
Individual depth proﬁles, and depth proﬁles aver-
aged over all slices, including the unstirred layer
above the slice surface, were ﬁtted with the non-linear
least-square curve ﬁtting function lsqcurveﬁt in
MATLAB. All ﬁts were evaluated by calculating the
proportion of the sum of the squared residuals (diﬀer-
ence between data and ﬁt) explained by the ﬁt (R2), and
all ﬁts in this paper had R2> 0.95.
Most analyses involved measuring the [O2] proﬁle
through the depth of the slice; however, some experi-
ments examined only the [O2] on the slice surface.
Although the surface cell layer can be damaged by
the slicing process33,56 up to a depth of 10 to 35 mm,
this does not invalidate the use of surface [O2] measure-
ments to assess the [O2] consumption of the slice,
because the surface [O2] does not just reﬂect local meta-
bolic activity, but reﬂects O2 use throughout the slice
and thus changes when metabolic activity is altered (see
plots in Figures 4(a) and (b), 5(a) and (b) and 6(a)).
Statistics
Data are shown as mean standard error of the mean
(s.e.m.). After conﬁrming that the data were normally
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Figure 1. Measuring oxygen and calculating energy use in a brain slice. (a) A Clark-type oxygen sensor was used to measure oxygen
concentration during the experiment (electrode schematic adapted from Unisense:49 for sensor information see Supplementary
Methods). (b) Experimental outline. The oxygen sensor was placed at the surface (touching the tissue) of the hippocampal brain slice at
the start of the experiment. After 10min of baseline measurement, a depth profile of O2 concentration was obtained by moving the
electrode along its own axis to generate a vertical depth of 50, 100, and 150 mm (the midpoint of the slice) into the slice (see
Supplementary Methods). After obtaining the [O2] depth profile, the electrode was returned to the surface. Depth profiles measured
with a greater spatial resolution, or with measurement points beyond the slice midpoint, did not affect the calculation of oxygen
consumption through the slice (see Supplementary Figure 3). A specific blocker of an energy-consuming process was bath-perfused
onto the slice for 7–20min (see Materials and Methods and Supplementary Methods). A second [O2] depth profile was obtained at the
end of the drug application, when the oxygen level had reached a plateau. After a 10–15min recovery period and a third [O2] depth
profile, 1mM glutamate was applied to the slice and a final [O2] depth profile was obtained after oxygen levels stabilized after 3–5min.
Above the slice surface, oxygen diffuses through an unstirred layer but is not consumed. (c) Sample depth profile for [O2] through a
hippocampal slice (CA1 region). The [O2] at the slice surface is lower than at the top of the static unstirred layer, where, in turn,
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distributed using the Kolmogorov–Smirnov test, one-way
or two-way ANOVAs (repeated measures where appro-
priate) or paired or one-sample t-tests were used to
compare means, and data were corrected for multiple
comparisons with Dunnett’s post hoc test or a modiﬁed
Holm–Bonferroni correction (see Supplementary
Methods). Degrees of freedom are reported in brackets
after the t or F statistic, respectively.
(continued)
the [O2] is lower than in the reservoir bubbled with 100% O2 (see (d)), as oxygen is lost to the air above the reservoir and through the
perfusion tube walls (see Results). (d) Oxygen sensor calibration. Three bottles of distilled water were heated up to 37C and bubbled
for at least 15min with 0%, 20%, and 95% oxygen. The electrode was then inserted into the three solutions consecutively for a few
seconds until a stable reading was obtained. Those readings were plotted against the dissolved oxygen concentrations corresponding
to the different percentage saturation values for oxygen in water at 37C, which were obtained from Henry’s law as 0, 208, and
991 mM, respectively.50 Using the slope and intercept from the linear fit through these three points, a linear conversion to mM was then
applied to the raw electrode output. (e) Oxygen measurements were taken at the end point of each depth step (blue dots).
Measurements were fitted (see Materials and methods and Supplementary methods) with a modified diffusion equation (equation (1))
from the top of the unstirred layer to give Vmax, the maximum rate of oxidative phosphorylation at saturating [O2]. (f) The width of the
unstirred layer was determined by moving the oxygen electrode upwards from the slice surface and calculating the break point of the
[O2] profile between the unstirred layer and the bulk solution above it (see Supplementary Methods).
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Figure 2. Baseline metabolic activity in a brain slice. (a) Constructing a hippocampal oxygen map of a P10 rat slice. The oxygen
sensor was used to measure surface oxygen levels at each point on the schematic. The points were binned into nine distinct areas,
colour-coded in (b). During the experiments reported subsequently in the paper, the electrode was placed in the CA1 region and
advanced down through the slice into the stratum lacunosum-moleculare. (b) Mean ( s.e.m.) of oxygen concentration binned into
the hippocampal regions shown in (a), n¼ nine slices, N¼ three animals. The following area measurements were binned: DGG
(dentate gyrus granule cells) points 1–6, DG (dentate gyrus) 7–8 and 25–26, CA4 9, CA3P (CA3 pyramidal cells) 10–14, CA2P (CA2
pyramidal cells) 15–16, CA1P (CA1 pyramidal cells) 17–18, SL-M (stratum lacunosum-moleculare) 19–22, MFP (mossy fibre pathway)
23–24, and F (fimbria hippocampus) 27–28. No significant difference in oxygen level between hippocampal regions was found
(p¼ 0.44). (c) Signalling related energy expenditure is negligible in a resting slice. Specific blockers of postsynaptic currents (and thus
postsynaptic action potentials, 10 mM NBQXþ 50 mM D-AP5, n¼ nine slices, N¼ four animals), presynaptic transmitter release and
postsynaptic events (250 mM cadmium, n¼ 6, N¼ 2) or action potentials and synaptic events (1 mM TTX, n¼ 9, N¼ 9) were applied
to different slices. Changes in oxygen level between the start of drug application and 15min later were measured in those blockers and
in a no-drug baseline condition (n¼ 9, N¼ 9). No blocker changed oxygen levels relative to control (p¼0.26).
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Results
Baseline hippocampal oxygen levels
are uniform in hippocampal slices
The hippocampus comprises diﬀerent functional areas
which might have diﬀerent baseline energy uses. The
oxygen electrode moved laterally through the slice
when lowered along its axis so, although it mostly
remained in the CA1 region, we investigated whether
regional diﬀerences in baseline [O2] might aﬀect our
results. We tested this by measuring the oxygen level
at the slice surface at 28 points across 9 hippocampal
regions (Figure 2(a) and (b)). No signiﬁcant diﬀerence
in [O2] across regions was detected (F(8,72)¼0.44,
p¼ 0.89, n¼nine slices), suggesting no signiﬁcant dif-
ference in O2 use between hippocampal areas. This
implies that moving the oxygen electrode across the
slice during the process of lowering it into the slice
would not have an eﬀect on the measured [O2].
No O2 use associated with spontaneous
activity can be detected in brain slices
Most brain energy is used on synaptic and action
potentials,1 and this can be detected as changes of
[O2] level in response to electrical stimulation in hippo-
campal slices.51 However, endogenous synaptic activity
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Figure 3. Sample traces for blockers of energy-consuming processes. Traces show oxygen levels on the slice surface interspersed
with [O2] depth profiles (light blue bars). Oxygen levels rise when less oxygen is being consumed and fall when more oxygen is
consumed (the grey dotted line is placed at the initial [O2] level at the slice surface for easier comparison). After 10min of baseline
(here only 5min is shown before drug onset), the specific blocker of a non-signalling process was bath-perfused onto the slice (black
bar), followed by 10–15min of recovery and wash-in of 1mM glutamate (open bar). Blocker application times are given in the
Supplementary Methods. (a) antimycin stops all oxidative phosphorylation: near the end of the trace the variation of [O2] with depth is
abolished, (b) cytochalasin D blocks actin treadmilling, (c) nocodazole inhibits microtubule turnover, (d), TOFA arrests lipid synthesis,
(e) anisomycin blocks protein synthesis and (f) ouabain inhibits the sodium–potassium ATPase (no calcium in the external solution).
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is less in brain slices than in the brain, because
long-range connections are disrupted by the slicing.
We investigated oxygen use evoked by spontaneous
electrical activity by blocking either postsynaptic cur-
rents (using 10 mM NBQXþ 50 mM D-AP5, n¼ nine
slices), presynaptic transmitter release and postsynaptic
events (using 250 mM cadmium, n¼ six slices), or action
potentials and synaptic events (using 1 mM TTX,
n¼ nine slices). None of these manipulations signiﬁ-
cantly changed the oxygen level at the slice surface
(F(3,29)¼1.4, p¼ 0.26, Figure 2(c)), suggesting that
ongoing electrical activity in the slice is too weak to
be detected from its O2 consumption. The absence of
spontaneous signalling activity facilitated selective
measurement of the O2 use of non-signalling processes,
but also implies that the percentage of O2 use that we
measure for non-signalling tasks (below) would be a
smaller percentage of total brain O2 consumption in
vivo, where synaptic and action potentials consume
more energy (see Discussion).
Unstirred layer parameters
In the following experiments, we ﬁt measurements of O2
concentration throughout the slice and the unstirred layer
above the slice to obtain a value for the rate of oxygen
consumption in the slice. We incorporated the value of
[O2] at the top of the unstirred layer (which corresponds
to the oxygen level in the bulk solution) in order to more
accurately estimate changes in O2 consumption in the slice
from changes in the O2 depth proﬁles (see Materials and
Methods and Supplementary Methods). The unstirred
layer width averaged across the cytochalasin D, nocoda-
zole, ouabain, and anisomycin conditions in 17 slices was
235 10mm, and the [O2] in the bulk solution at the top
of the unstirred layer was 0.57 0.05mM (less than the
1.04mM in the solution reservoir bubbled with 100% O2
due to O2 loss to the air above the reservoir and through
the perfusion tube walls). Neither the width of the
unstirred layer nor the [O2] at the top of the unstirred
layer diﬀered signiﬁcantly between these conditions
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Figure 4. Actin cytoskeleton treadmilling accounts for about a quarter of resting energy use, and microtubule turnover uses a
similar fraction of the brain’s energy. (a), (b) Average oxygen concentration (mM s.e.m.) depth profiles for each condition
(black¼ baseline, red¼ 10mM cytochalasin D in (a) and 25 mM nocodazole in (b), green¼ recovery, blue¼ 1mM glutamate), for block
of actin ((a), n¼ eight slices, N¼ six animals) and microtubule ((b), n¼ 8, N¼ 4) turnover. Data were fitted with equation (1) from the
surface to the bottom of the slice, and with equation (1) but without the oxygen consumption term across the unstirred layer to the
slice surface. The fit gives Vmax, the maximum rate of oxygen use. (c), (d) Averaged Vmax  s.e.m. (red dots) and individual Vmax values
(black dots, normalised to baseline Vmax (¼1)) for block of actin ((c), n¼ 8) and microtubule ((d), n¼ 8) turnover. The average
fractional rate of energy consumption relative to baseline was calculated from the average of individual fits as being 75% during actin
treadmilling inhibition and 78% during microtubule turnover block.
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(F(3,13)¼2.8, p¼ 0.08 and F(3,13)¼2.2, p¼ 0.13, respect-
ively, n¼ 17 slices).
For experiments containing albumin as a carrier pro-
tein for the lipid synthesis blocker TOFA, the unstirred
layer parameters were signiﬁcantly diﬀerent. The
unstirred layer width in four slices was 165 21 mm,
and the [O2] at the top of the unstirred layer was
0.86 0.45mM. In the bulk solution outside the
unstirred layer (unaﬀected by the slice’s oxygen con-
sumption), the [O2] above 17 slices superfused with
solution not containing albumin was 0.59 0.04mM,
but was 0.92 0.02mM when external solutions con-
taining albumin were used. Therefore, the raised base-
line [O2] in experiments using solutions containing
albumin (described below) is an eﬀect of a greater sat-
uration of the bulk solution with oxygen, which may
come about because the albumin foam formed on the
surface of solution bubbled with gas impedes the loss of
the bubbled O2 to the air above.
Blocking all oxidative phosphorylation raises the [O2]
to the bulk solution level
In order to conﬁrm that our method of measuring [O2]
in a brain slice with an oxygen electrode does indeed
reﬂect changes in cellular respiration, we veriﬁed that
blocking all oxidative phosphorylation in a brain slice
elevated [O2] at the slice surface to bulk solution levels.
Application of 25 mM antimycin, a respiratory chain
inhibitor, increased the oxygen concentration at the
slice surface within one to two minutes of application.
After 15min, the oxygen concentration at the surface of
the slice (0.60 0.02mM) was not signiﬁcantly diﬀerent
from that in the bulk solution of the bath (which in
these experiments was 0.66 0.01mM, t(3)¼1.88,
p¼ 0.16, n¼ slices slices) and was much larger than
the surface oxygen level before drug application
(0.240.06mM). Consistent with this, the variation
of [O2] with depth was abolished within minutes when
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Figure 5. Lipid and protein synthesis together account for about 18% of O2 use, but O2 use on protein synthesis alone is too small
to be measured. (a), (b) Average oxygen concentration  s.e.m. across depth profiles per condition (black¼ baseline, red¼ 60 mM
TOFAþ 20 mM anisomycin in (a) or 20mM anisomycin in (b), green¼ recovery, blue¼ 1mM glutamate) for block of lipid and protein
synthesis ((a), n¼ five slices, N¼ two animals) and protein synthesis alone ((b), n¼ 4, N¼ 4). (c), (d) Average Vmax  s.e.m. (red dots)
and individual Vmax (black dots, normalised to baseline Vmax (¼1)) for block of lipid and protein synthesis ((a), n¼ 5) and protein
synthesis alone ((b), n¼ 4). The average energy consumption was 82% of the control value when lipid and protein synthesis were
blocked. No change could be detected when protein synthesis alone was inhibited.
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oxygen consumption throughout the whole slice ceased
(Figure 3(a)).
Oxygen level changes after block
of non-signalling processes
Figure 3(b) to (e) shows sample traces for oxygen level
changes at the slice surface for each non-signalling pro-
cess that was blocked and the recovery of the oxygen
level after the blocker was removed, while Figure 3(e)
shows oxygen level changes after block of the sodium
pump. At the end of each experiment, to check the
health of the slice, 1mM glutamate was applied to acti-
vate a cation inﬂux through ionotropic receptors and
thus increase oxygen consumption. For all drugs, oxygen
level was measured as a function of depth in the slice,
and these depth proﬁles were used to calculate the rate of
oxygen consumption through the slice, by solving a
modiﬁed diﬀusion equation (see Materials and methods
and Supplementary methods). These rates of oxygen
consumption are quantiﬁed in Figures 4 to 6.
Blocking actin or microtubule cycling
reduces oxygen consumption
To investigate the eﬀect on energy consumption of
blocking actin treadmilling, 10mM cytochalasin D was
applied to the slice to arrest actin polymerisation. At the
end of the cytochalasin D application (Figure 3(b)), the
oxygen level at the slice surface was elevated from
0.33 0.02mM to 0.43 0.02mM (n¼ 8), suggesting
that some slice oxygen consumption is due to actin
treadmilling. On removing cytochalasin D, the oxygen
level recovered to 0.32 0.02mM (Figure 4(a)).
Subsequently, applying glutamate lowered the surface
oxygen level to 0.23 0.02mM, reﬂecting oxygen
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Figure 6. Block of the sodium–potassium ATPase nearly halves oxygen use in the absence of external calcium. (a), (b) Averaged
oxygen concentration  s.e.m. across depth profiles per condition (black¼ baseline, red¼ 1mM ouabain) for inhibition of the
sodium–potassium pump in the absence ((a), n¼ seven slices, N¼ two animals) and presence ((b), n¼ 4, N¼ 4) of external calcium.
Slices did not recover after ouabain application and did not react to glutamate (data not shown). (c), (d) Averaged Vmax  s.e.m. (red
dots) and individual Vmax values (black dots, normalised to baseline Vmax (¼1)) for inhibition of the sodium–potassium pump in the
absence ((c), n¼ 7) and presence ((d), n¼ 4) of external calcium. In ouabain, the average energy consumption was 50% of the control
value in the absence of external calcium, an effect masked by the presence of calcium (see Results and Discussion).
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consumption to fuel synaptic depolarisation. A two-way
repeated measures ANOVA for treatment (baseline,
cytochalasin D, recovery, glutamate) and position in
the slice (surface, 50mm, 100mm, 150mm) showed
a main eﬀect of condition on oxygen level across all
depths used in the depth proﬁle (F(3,21)¼33.9, p¼
2.1 108, n¼ eight slices). With Dunnett’s post-hoc
test, the oxygen levels in cytochalasin diﬀered signiﬁ-
cantly from control (t(21)¼8.42, p¼ 9.1 109), and
there was no diﬀerence in the oxygen levels between
the baseline and recovery conditions (t(21)¼1.01,
p¼ 0.63). Glutamate application also signiﬁcantly chan-
ged the oxygen levels relative to baseline (t(21)¼10.81,
p¼ 3.9 1012, n¼ eight slices). Similarly, when 1mM
jasplakinolide, another actin cycling blocker that can,
however, also promote polymerization,38 was applied,
the surface oxygen level rose from 0.23 0.03mM to
0.28 0.02mM (t(6)¼5.56, p¼ 0.004) in three slices.
We then modelled the rate of oxygen consumption
through the slice. After the [O2] depth proﬁles were ﬁt
(Figure 4(a)) with the modiﬁed diﬀusion equation
(equation (1)) incorporating the unstirred layer, the
resulting values of Vmax, the maximum rate of oxidative
phosphorylation at saturating [O2], were normalised to
the initial control value for each slice. On average, the
Vmax in cytochalasin D was 0.75 0.05 of that in the
initial control condition (Figure 4(c), t(7)¼4.8, p¼
0.005, n¼ eight slices). On removing cytochalasin D,
Vmax recovered to 1.03 0.04 of the initial control
value (t(7)¼0.88, p¼ 0.41). In glutamate, the average
Vmax rose to 1.70 0.1 of the initial control value
(Figure 4(c), t(7)¼4.29, p¼ 0.007, n¼ eight slices).
These results suggest that a signiﬁcant fraction of the
slice’s resting energy budget, 25%, is spent on actin
cycling. Two-photon imaging of ongoing microglial
motility before and after the application of cytochalasin
D conﬁrmed that the drug rapidly and eﬀectively inhib-
ited microglial movement and therefore actin cycling
(Supplementary Figure 1(c), n¼ 15 cells from ﬁve slices).
In order to inhibit microtubule turnover, 25 mM
nocodazole, a microtubule-depolymerising agent was
perfused onto the slice. Microtubule turnover also con-
tributes to resting brain slice oxygen use, as applying
nocodazole (Figure 3(c)) raised the oxygen level at the
slice surface from 0.28 0.02mM to 0.36 0.03mM.
This recovered to 0.30 0.03mM on removing the
nocodazole (Figure 4(b)), while glutamate lowered the
surface oxygen level to 0.22 0.02mM (n¼ 8). A two-
way repeated measures ANOVA again showed a main
eﬀect of condition on oxygen level across all depths in
the slice (F(3,21)¼37.8, p¼ 1.2 108, n¼ eight slices).
Oxygen levels across depth in nocodazole diﬀered sig-
niﬁcantly from baseline (Figure 4(b), t(21)¼8.03,
p¼ 2.9 108) and the surface oxygen level after recov-
ery from nocodazole application was indistinguishable
from baseline (t(21)¼1.59, p¼ 0.29). Similarly, glutam-
ate application signiﬁcantly lowered [O2] relative to the
control condition (t(21)¼ 7.28, p¼ 2.6 107, n¼ eight
slices).
As in the previous experiment, these data were used
to model oxygen consumption through the slice. When
microtubule turnover was blocked with nocodazole
(Figure 4(d)), the Vmax derived from the [O2] depth
proﬁles was reduced to 0.78 0.04 (t(7)¼5.6, p¼
0.002, n¼ eight slices) of the control value, and recov-
ered to 0.96 0.03 of the control value on removing
nocodazole (t(7)¼1.9, p¼ 0.09). In glutamate, Vmax
increased to 1.48 0.10 of the baseline value (t(7)¼4.6,
p¼ 0.005, n¼ eight slices). Surprisingly, therefore,
microtubule turnover also accounts for a substantial
22% of the slice’s baseline oxygen use. After the slices
recovered from either actin or microtubule turnover
inhibition, activating glutamate receptors throughout
the slice by superfusing glutamate increased the
energy use by 50–70%. The magnitude of the Vmax
change after glutamate application was not signiﬁcantly
diﬀerent in the cytochalasin D versus the nocodazole
condition (t(14)¼0.4, p¼ 0.67).
Since excitatory synaptic currents are thought to con-
sume most ATP in the brain,9 we were concerned that our
estimates of the energy use on cytoskeletal recycling could
be confounded if the drugs used aﬀected the frequency of
excitatory synaptic currents (see Supplementary Figure 1(a)
and (b)). We therefore whole-cell patch-clamped area CA1
pyramidal cells and monitored spontaneous EPSCs while
applying either cytochalasin D or nocodazole (see
Supplementary Methods). Neither drug signiﬁcantly
altered the number of EPSCs occurring during the last
6min in each condition (F(2,14)¼1.69, p¼ 0.23 for cyto-
chalasin D and F(2,8)¼0.56, p¼ 0.59 for nocodazole, both
n¼ eight slices).
The energy used on lipid and protein synthesis
We next investigated the contributions of phospholipid
and protein synthesis to the slice’s energy expenditure.
Previous estimates of the energy consumption of protein
synthesis are unanimously very low, at 2% of the total
energy budget,1,14,29 but vary between 2% and 25% for
lipid metabolism.14,30,31,57 We ﬁrst applied blockers of
both phospholipid synthesis (60mm TOFA) and protein
synthesis (20mM anisomycin) together. In the experi-
ments containing TOFA, serum albumin had to be pre-
sent in the external solutions to prevent precipitation of
the drug. Albumin increased the concentration of
oxygen in the solutions (see above), which altered
oxygen levels at the slice surface (F(2,16)¼12.74, p¼
0.006, n¼ four slices). Application of 0.5% albumin
(together with 0.55% DMSO) reversibly raised the
oxygen level at the surface of the resting slice from
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0.34 0.03mM to 0.56 0.06mM (t(6)¼10.1, p¼
0.8 105). The surface oxygen level recovered to
0.34 0.05mM after albumin was washed oﬀ (t(6)¼41,
p¼ 0.88, n¼ four slices). As albumin was added to all
solutions in the lipid synthesis block experiments, the
baseline oxygen level was uniformly raised throughout
these experiments. To test whether, by altering the
oxygen level in the superperfused solution, albumin
changed the oxygen consumption of the slice in control
conditions, we assessed the total oxygen consumption as
being proportional to the amount of O2 diﬀusing
through the unstirred layer towards the slice. This ﬂux
is proportional to the diﬀerence between the oxygen level
at the top of the unstirred layer (a mean value for which
was averaged over all slices) and at the slice surface
(measured for each individual slice), divided by the
width of the unstirred layer (averaged over all slices).
This parameter did not diﬀer between experiments with-
out albumin in the external solution (1.22 0.07, n¼ 31
slices) and those using external albumin (1.36 0.26,
n¼ﬁve slices, t(34)¼0.7, p¼ 0.49).
After lipid and protein synthesis were blocked using
60 mM TOFA and 20 mM anisomycin (Figure 5(a)), the
oxygen level at the slice surface rose from 0.63
0.04mM to 0.68 0.04mM (t(12)¼6.2, p¼ 7.0 105).
On removal of the drugs, the [O2] recovered to
0.64 0.03mM (t(12)¼2.06, p¼ 0.14), and on applying
glutamate it fell to 0.49 0.05mM (t(12)¼17.01,
p¼ 4.4 1016). An overall two-way repeated measures
ANOVA showed a main eﬀect of condition on oxygen
levels across depths (F(3,12)¼79.1, p¼ 3.75 108,
n¼ ﬁve slices).
We then blocked protein synthesis alone with 20mM
anisomycin (Figure 5(b)) to isolate its contribution to the
slice’s oxygen consumption. There was no signiﬁcant
change in oxygen level at the slice surface between base-
line (0.32 0.05mM), anisomycin (0.32 0.05mM, t(9)
¼0.66, p¼ 0.85) and recovery (0.33 0.04mM, t(9)¼
0.96, p¼ 0.67). However, [O2] again fell signiﬁcantly
in glutamate to 0.23 0.04mM (t(9)¼10.98, p¼
2.14 107).
When modelling the rate of oxygen consumption
through the slice, the Vmax for O2 usage after inhibition
of both lipid and protein synthesis (Figure 5(c)) fell to
0.82 0.05 of the control value (t(4)¼4.1, p¼ 0.04),
recovered to 0.96 0.07 of the control value on remov-
ing the blockers (t(4)¼0.66, p¼ 0.54), and increased
to 1.63 0.15 of the control value (t(4)¼4.61, p¼ 0.02)
in glutamate. For protein synthesis block alone
(Figure 5(d)), the Vmax for O2 usage in anisomycin rela-
tive to baseline was 1.03 0.03, not signiﬁcantly diﬀer-
ent from the control value (t(3)¼1.15, p¼ 0.33). After
removing the drug, the recovery value was 0.97 0.02
of the control value (t(3)¼1.9, p¼ 0.30), while Vmax
in glutamate rose to 1.54 0.08 of the control value
(t(3)¼6.39, p¼ 0.02). From the data above, it can there-
fore be estimated that lipid and protein synthesis
together require 18% of the brain’s resting O2 use.
Lipid synthesis likely account for most of this ﬁgure,
as protein synthesis uses too little of the slice’s resting
energy to be detected with the oxygen electrode.
Without external calcium, the Naþ/Kþ pump
accounts for 50% of energy use
Most brain ATP use is thought to be on the pumping
out of ions that enter neurons to generate synaptic or
action potentials, or that enter at the resting potential.9
This pumping is mainly carried out by the sodium
pump. To examine the fraction of energy expended
on sodium pumping in brain slices, we applied the
pump blocker ouabain (1mM). These experiments
were performed both in the presence and absence of
external calcium, because blocking the pump is
expected to lead indirectly to a rise of [Ca2þ]i which
can increase energy consumption (see Discussion).
For example, while Shibuki58 found that ouabain
decreased oxygen consumption in unstimulated neuro-
hypophysis slices whether or not calcium was present,
Rusˇcˇa´k and Whittam59 found that blocking the Naþ/
Kþ pump only decreased O2 consumption in cortical
slices when using Ca2þ-free external solutions, and
instead found an increase in O2 consumption when
the external solution contained Ca2þ. Because of
these varying results, we measured the eﬀect of blocking
the sodium pump on the [O2] proﬁle both in the pres-
ence and absence of external calcium.
After ouabain application in the absence of external
calcium, the oxygen level at the slice surface rose from
0.26 0.05mM to 0.38 0.05mM (Figure 6(a); recov-
ery and eﬀect of glutamate are not shown as the eﬀect
of ouabain was irreversible). The main eﬀect of ouabain
on oxygen levels was signiﬁcant at all depths in the
slice (F(3,18)¼17.86, p¼ 1.2 105, n¼ seven slices).
Oxygen levels in the presence of ouabain diﬀered
signiﬁcantly from those in control conditions
(t(18)¼11.55, p¼ 2.7 1012). In contrast, with exter-
nal calcium present, the oxygen level at the slice
surface rose from 0.17 0.02mM to 0.20 0.01mM
(Figure 6(b)) when ouabain was applied, which was not
signiﬁcant (F(3,6)¼1.32, p¼ 0.35, n¼ four slices). This is
presumably because the pump block raises [Ca2þ]i which
increases energy consumption (see Discussion).
When modelling the rate of oxygen consumption
through the slice, the average Vmax for oxygen usage
in ouabain without external calcium (Figure 6(c)) was
0.50 0.07 of the control value without calcium
(t(6)¼7.4, p¼ 3104, n¼ seven slices). With exter-
nal calcium present (Figure 6(d)), the Vmax after oua-
bain application was not signiﬁcantly diﬀerent from
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baseline (0.85 0.10 of the control value, t(3)¼1.5,
p¼ 0.23, n¼ four slices). Without external calcium,
blocking the sodium pump therefore approximately
halved the resting slice’s energy use, whereas no signiﬁ-
cant change in oxygen consumption could be detected
when ouabain was applied in the presence of external
calcium.
Discussion
Here, we have presented the ﬁrst experimental data
obtained with a single method investigating the relative
contributions of the main non-signalling processes to
the brain’s energy budget. This was done by inhibiting
these processes in young rat hippocampal slices and
measuring changes in oxygen consumption with a
Clark-type oxygen sensor. Surprisingly, the actin and
microtubule cytoskeletons contribute almost equally to
a large (47%) fraction of the brain slice’s resting
energy budget (Figure 4). The O2 use on actin turnover
(25%) is considerably lower than previous sugges-
tions23 that half of the energy use was spent on actin
turnover alone, but is much higher than our previous
modelling suggested.24
Lipid synthesis accounts for most of the remaining
non-signalling energy use (18% when blocked together
with protein synthesis), but blocking protein synthesis
did not detectably change energy use (Figure 5). These
results are consistent with previous estimates that protein
synthesis accounts for only 1.3% of the brain’s total
energy use.1,29 Purdon and Rapoport31,57 calculated that
up to 25% of the brain’s energy use might be spent on
phospholipid metabolism, although only 5% of the total
energy budget was estimated to be spent on the turnover
of fatty acids within phospholipids, with the rest allo-
cated to maintaining the phosphorylation state of
phospholipids (12%) and maintaining asymmetries in
the phospholipid bilayer (7.7%).
As in previous experiments in vivo12, inhibiting the
sodium–potassium pump approximately halved the total
energy expenditure in our brain slices. However, as in
cortical slices,58,59 this pronounced reduction in oxygen
consumption was seen only when external calcium was
absent, and the decrease in oxygen consumption was
inhibited when calcium was present in the external solu-
tion (Figure 6). It is known that, with extracellular cal-
cium present, blocking the sodium pump with ouabain
induces a rise of intracellular [Ca2þ]i, due to Na
þ gradi-
ent rundown and subsequent reversal of the Naþ/Ca2þ
exchanger60. This may, in turn, increase the activity of
oxygen-consuming processes (such as Ca2þ-ATPase
activity to remove the extra Ca2þ) as well as increasing
oxidative phosphorylation,61 which could occlude the
decrease in oxygen consumption produced by sodium–
potassium pump inhibition.
The contributions to O2 consumption of the sodium
pump (50%), cytoskeletal turnover (47%), and protein
and lipid synthesis (18%) that we have estimated sum
to slightly more than 100%. However, the sodium
pump contribution was calculated in the absence of
calcium, and furthermore the experimental results pre-
sented here need to be considered with several caveats.
First, we are assuming that oxygen consumption is
proportional to energy use, because under normal con-
ditions glucose is essentially completely oxidised in the
brain by the sequential operation of glycolysis and oxi-
dative phosphorylation.4,5 However, we cannot exclude
the possibility that, in our brain slices, glycolysis
accounts for a larger proportion of ATP generation
than in the normal brain. For example, microglia, the
brain’s immune cells, switch their energy production
mechanism from oxidative phosphorylation to glycoly-
sis in hypoxia62, and the relative rates of these processes
in astrocytes and neurons63 could diﬀer in slices and in
vivo. However, in these experiments, the slices were
superfused with 100% oxygen and thus were not lim-
ited by oxygen availability.
Second, there is a limit to the resolution of oxygen
measurements using Clark-type oxygen sensors.
Baseline recordings of brain oxygen levels show ﬂuctu-
ations of 25 mM oxygen over 15min (Figure 2(c),
baseline). The noise that this introduces, together with
block of the sodium–potassium pump being performed
in the absence of external calcium, could account
for the sum of the contributions of all processes exceed-
ing 100%.
How can our estimates of non-signalling energy use
in brain slices be extrapolated to the awake brain?
Oxidative phosphorylation is lower in unstimulated
brain slices than in vivo, since there is little spontaneous
neuronal activity in slices (Figure 2(c)). The resting
oxygen consumption in our experiments (in P10 rats)
was 0.47 0.03mM/min at 37C, while 0.7mM/min
was found previously in coronal brain slices of P21
rats at 35C51, 0.8mM/min in cultured cerebellar
slices of P8 rats, and 1.3mM/min in acute cerebellar
slices of P10 rats, both at 37C.64 However, oxygen
consumption is higher in vivo: in anaesthetized rats,
the CMRO2 at 37
C is approximately 1.8mM/min,65
while Sokoloﬀ et al.66 estimated glucose consump-
tion in the grey matter of conscious adult rats to be
1mM/min, implying an oxygen consumption of
6mM/min. In awake humans, the whole-brain averaged
CMRO2 is around 1.3mM/min.
67 The much lower
oxygen consumption in our data (0.47 0.03mM/min
under baseline conditions) presumably reﬂects the
young age of the animal and the presence of little neur-
onal activity in the slice (Figure 2(c)) which is a major
contributor to oxygen use.51,63,68–71 Interestingly, unlike
our data in Figure 2(c), Huchzermeyer et al.68 found a
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rise in oxygen level in organotypic slices following the
application of TTX, implying that suﬃcient spontaneous
activity was occurring to generate detectable O2 use.
Whether this reﬂects the use of organotypic slices or of
an interface chamber69 by Huchzermeyer et al.,68 as
opposed to the submerged acute slices used in this
study, is unclear.
If the non-signalling energy use were the same inde-
pendent of age, brain location or level of neuronal activ-
ity, then the percentage contributions of non-signalling
energy processes to the total energy budget would be
signiﬁcantly smaller in vivo than we calculate above.
However, non-signalling processes are not completely
uncoupled from signalling activity: for instance, actin
turnover is regulated by neuronal activity, with faster
treadmilling after block of neuronal activity and reduced
motility due to actin stabilisation after NMDA applica-
tion.19,72 This would imply that the energetic cost of
actin cycling in brain slices, with little neuronal activity,
is higher than in the intact brain.
It is also likely that non-signalling processes in more
mature animals have a diﬀerent energy demand from
those at the early developmental stage used here (P10)
when cell processes are still being extended. Energy
metabolism as a whole changes: at P10, rodents may
lack full capabilities for oxidative phosphorylation,
which might explain the lower baseline Vmax in our
slices compared to those from older animals,50 and
neuronal function is more resistant to oxygen depriv-
ation than in mature rats.73 In the case of the actin
cytoskeleton, developmental changes occur: motility
in highly dynamic dendritic spines decreases signiﬁ-
cantly between P10 (a peak time for synaptogenesis)
and P20 in cortical mouse slices.74 Total actin levels
in the brain also peak at an early stage of development
and later decline.75 This would again imply that actin
recycling uses less energy in vivo than in our brain
slices. The pattern of microtubule spatial organisation
also shifts during early development: uniformly high-
polymerisation rates throughout neuronal axons and
dendrites in the ﬁrst days of development give way to
more stable proximal regions in older cultured neurons,
while more dynamic distal regions maintain high poly-
merisation rates.76 Furthermore, de novo phospholipid
and protein synthesis both decline with age.77 Non-sig-
nalling processes are thus developmentally regulated,
and it would be valuable to repeat the experiments pre-
sented here at diﬀerent stages of development. Here, we
have presented data at P10, an age of rapid synapse
restructuring and synaptogenesis.78 It would be inter-
esting to investigate whether the energetic cost of actin
cycling decreases after P20, when synapses have sta-
bilised and less cytoskeletal rearrangement is needed. In
addition, it would be interesting to test for regional
diﬀerences in the non-signalling energy budget.
In summary, contributions of non-signalling pro-
cesses to the brain’s energy budget can be signiﬁcant,
but are probably dynamic and likely to change during
development or with changes in the brain’s functional
state. Pathology will also alter non-signalling processes
and their energetic consumption. Alzheimer’s disease
(AD), in which energy supply is impaired, aﬀects actin
and microtubule turnover.79,80 Coﬁlin, an actin-binding
protein, may link cytoskeletal aberrations to mitochon-
drial impairments characteristic not only of AD, but
also of related pathologies such as Parkinson’s
and Huntington’s disease.81 Understanding how non-
signalling processes contribute to the brain’s energy
budget is therefore important. As a ﬁrst step, we have
found that both actin and microtubule cytoskeleton
turnover are surprisingly signiﬁcant energy drains in
the healthy developing brain, with lipid synthesis close
behind. In contrast, protein synthesis is energetically
inexpensive.
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